These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

890 related items for PubMed ID: 2110013

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals.
    Sugrue MF, Mallorga P, Schwam H, Baldwin JJ, Ponticello GS.
    Curr Eye Res; 1990 Jun; 9(6):607-15. PubMed ID: 2117519
    [Abstract] [Full Text] [Related]

  • 3. MK-927: a topically active ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF, Gautheron P, Grove J, Mallorga P, Viader MP, Schwam H, Baldwin JJ, Christy ME, Ponticello GS.
    J Ocul Pharmacol; 1990 Jun; 6(1):9-22. PubMed ID: 2362161
    [Abstract] [Full Text] [Related]

  • 4. A comparison between the effect of topical and systemic carbonic anhydrase inhibitors on aqueous humor secretion.
    Brechue WF, Maren TH.
    Exp Eye Res; 1993 Jul; 57(1):67-78. PubMed ID: 8405174
    [Abstract] [Full Text] [Related]

  • 5. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor.
    Sugrue MF.
    J Ocul Pharmacol Ther; 1996 Jul; 12(3):363-76. PubMed ID: 8875343
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys.
    Wang RF, Serle JB, Podos SM, Sugrue MF.
    Arch Ophthalmol; 1991 Sep; 109(9):1297-9. PubMed ID: 1929960
    [Abstract] [Full Text] [Related]

  • 8. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route.
    Maren TH, Bar-Ilan A, Conroy CW, Brechue WF.
    Exp Eye Res; 1990 Jan; 50(1):27-36. PubMed ID: 2307193
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys.
    Wang RF, Serle JB, Podos SM, Sugrue MF.
    Arch Ophthalmol; 1990 Apr; 108(4):511-3. PubMed ID: 2322152
    [Abstract] [Full Text] [Related]

  • 11. Comparison of intraocular pressure lowering by topical and systemic carbonic anhydrase inhibitors in the rabbit.
    Fanous MM, Challa P, Maren TH.
    J Ocul Pharmacol Ther; 1999 Feb; 15(1):51-7. PubMed ID: 10048347
    [Abstract] [Full Text] [Related]

  • 12. [Pharmacological profiles of the potent carbonic anhydrase inhibitor dorzolamide hydrochloride, a topical antiglaucoma agent].
    Kobayashi M, Naito K.
    Nihon Yakurigaku Zasshi; 2000 Jun; 115(6):323-8. PubMed ID: 10948564
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor.
    Sharir M, Pierce WM, Chen D, Zimmerman TJ.
    Exp Eye Res; 1994 Jan; 58(1):107-16. PubMed ID: 8157096
    [Abstract] [Full Text] [Related]

  • 14. Preclinical studies on L-671,152, a topically effective ocular hypotensive carbonic anhydrase inhibitor.
    Sugrue MF, Mallorga P, Schwam H, Baldwin JJ, Ponticello GS.
    Br J Pharmacol; 1989 Dec; 98 Suppl():820P. PubMed ID: 2611526
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of topical carbonic anhydrase inhibitor (MK-507) on intraocular pressure of normal human eyes].
    Yamazaki Y, Miyamoto S, Sawa M.
    Nippon Ganka Gakkai Zasshi; 1994 Mar; 98(3):293-7. PubMed ID: 8154389
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151.
    Bar-Ilan A, Pessah NI, Maren TH.
    J Ocul Pharmacol; 1986 Mar; 2(2):109-20. PubMed ID: 3503100
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.
    Rosenberg LF, Krupin T, Tang LQ, Hong PH, Ruderman JM.
    Ophthalmology; 1998 Jan; 105(1):88-92; discussion 92-3. PubMed ID: 9442783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.